PATRICK G. LEPORE - 15 Nov 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role: Director
Signature: /s/ Mutya Harsch, as attorney-in-fact for Patrick G. LePore
Issuer symbol: VYNE
Transactions as of: 15 Nov 2023
Net transactions value: +$50,778
Form type: 4
Filing time: 17 Nov 2023, 17:03:12 UTC
Previous filing: 22 Mar 2023
Next filing: 15 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNE	Common Stock	Purchase	$50,778	+13,000	+55%	$3.91	36,472	15 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.